However, MC5R is reported to protect from uveitis-derived retinal damage by regulating the activation of CD4+ regulatory T cells (Taylor et al., 2006) and to attenuate retinal degeneration in an experimental model of diabetic retinopathy (Rossi et al., 2016). The gene discussed is CD4; the disease is uveitis.